© 2000 European Society of Cardiology
Comparison of different methods of functional evaluation in patients with chronic heart failure
Istituto di Clinica Medica e Cardiologia, Università di Firenze Viale GB Morgagni 85, 50134 Florence, Italy
* Corresponding author. Tel.: +39-055-436-0976; fax: +39-055-427-7608. E-mail address: g.gensini{at}dfc.unifi.it (C. Rostagno).
| Abstract |
|---|
Background: Stratification of the severity of heart failure has major prognostic and therapeutic implications.
Aims: To prospectively compare different methods of assessment of functional capacity in patients with chronic heart failure (CHF).
Methods and results: We studied 143 patients (78 male and 65 female) with CHF aged less than 70 years (mean 57.3 years). Functional assessment was made clinically according to NYHA classification and according to the Goldman Activity Scale Classification (GASC). Cardiovascular performance was measured by peak O2 consumption (pVO2) and anaerobic threshold (AT) at cardiopulmonary exercise test and by the distance walked during a 6-min walk test (6-MWT). Clinical scales resulted significantly related. Peak VO2 and AT showed a mild relation with distance covered at 6-MWT (r = 0.56 and r = 0.46, respectively). Concordance between NYHA classification and levels of performance at cardiopulmonary exercise test or at 6-MWT was less than 50%.
Conclusion: Our results suggest that none of the usually employed methods give a definitive assessment of functional capacity of cardiovascular system and a high degree of discordance exists among the results of different tests in the same patient. Although NYHA classification maintains its value in clinical evaluation of patients with CHF, the 6-min walk test is recommended in patients with mild-to-moderate CHF (II–III NYHA classes) as a simple and useful screening test to select patients for further diagnostic evaluation.
Key Words: Chronic heart failure Goldman Activity Scale Classification (GASC) Cardiovascular performance
Received December 22, 1999; Revised April 10, 2000; Accepted May 23, 2000
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Kim, S. J. Pressler, J. L. Welch, and W. J. Groh Validity and Reliability of the Chronic Heart Failure Questionnaire Mastery Subscale in Patients With Defibrillators West J Nurs Res, December 1, 2009; 31(8): 1057 - 1075. [Abstract] [PDF] |
||||
![]() |
V. L. Wittmer, G. M. S. Simoes, L. C. M. Sogame, and E. C. Vasquez Effects of continuous positive airway pressure on pulmonary function and exercise tolerance in patients with congestive heart failure. Chest, July 1, 2006; 130(1): 157 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dore, C. Houde, K.-L. Chan, A. Ducharme, P. Khairy, M. Juneau, F. Marcotte, and L.-A. Mercier Angiotensin Receptor Blockade and Exercise Capacity in Adults With Systemic Right Ventricles: A Multicenter, Randomized, Placebo-Controlled Clinical Trial Circulation, October 18, 2005; 112(16): 2411 - 2416. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-P. Diller, K. Dimopoulos, D. Okonko, W. Li, S. V. Babu-Narayan, C. S. Broberg, B. Johansson, B. Bouzas, M. J. Mullen, P. A. Poole-Wilson, et al. Exercise Intolerance in Adult Congenital Heart Disease: Comparative Severity, Correlates, and Prognostic Implication Circulation, August 9, 2005; 112(6): 828 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O'Meara, S. Solomon, J. McMurray, M. Pfeffer, S. Yusuf, E. Michelson, C. Granger, B. Olofsson, J. B. Young, and K. Swedberg Effect of candesartan on New York Heart Association functional class: Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme Eur. Heart J., November 1, 2004; 25(21): 1920 - 1926. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Meyer, M. Karamanoglu, A. A. Ehsani, and S. J. Kovacs Left ventricular chamber stiffness at rest as a determinant of exercise capacity in heart failure subjects with decreased ejection fraction J Appl Physiol, November 1, 2004; 97(5): 1667 - 1672. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Bibbins-Domingo, F. Lin, E. Vittinghoff, E. Barrett-Connor, D. Grady, and M. G. Shlipak Renal insufficiency as an independent predictor of mortality among women with heart failure J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1593 - 1600. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.X Kleber, P Waurick, and M Winterhalter CPET in heart failure Eur. Heart J. Suppl., August 1, 2004; 6(suppl_D): D1 - D4. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Rostagno, G. Olivo, M. Comeglio, V. Boddi, M. Banchelli, G. Galanti, and G. F. Gensini Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation Eur J Heart Fail, June 1, 2003; 5(3): 247 - 252. [Abstract] [Full Text] [PDF] |
||||







